Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Oct 1;7(9):1796–1810. doi: 10.1182/bloodadvances.2022007936

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PMC Copyright notice

Figure 3. — Modeling serum tryptase levels based on genotype improves clinical utility. (A) Normalized (left) and total (right) read counts for reads aligning exactly to the 39-bp consensus sequences that identify β-, α^WT-, and α^DUP-tryptase. (B) BST levels among individuals with conserved 4n tryptase copy number (combined from TPSAB1 and TPSB2). (C) Regression analysis of relative expression levels of α^DUP-tryptase (y-axis) and α^WT-tryptase (x-axis) transcripts. (D) Prediction intervals for BST levels based on TPSAB1 replication number. (E) Prevalence of HαT, clonal MCD, and those without either among individuals referred with BST levels above the predicted upper limit of normal (>11.4 ng/mL). ∗P < .01; ∗∗P < .005; ∗∗∗P < .0001.